• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸道合胞病毒的影响:对管理式医疗的启示

Impact of RSV: implications for managed care.

作者信息

Makari Doris, Hoopes J Michael, White Norman

机构信息

Medical and Scientific Affairs, Medlmmune, LLC.

出版信息

Manag Care. 2009 Jan;18(1 Suppl 2):2-7.

PMID:19230529
Abstract

Severe RSV disease, manifested as bronchiolitis or pneumonia, is the leading cause of hospitalization of infants younger than 1 year of age in the United States. Infants born 35 weeks or less GA are particularly at high risk of severe RSV disease, which may result in frequent NICU admissions or long hospital stays and additional health care utilization over the first 12 months of life. This care is costly--infants 33 to 36 weeks GA with a history of RSV hospitalization incur costs that are nearly 5 times as much as costs for 33 to 36 weeks GA infants with no history of RSV hospitalization. Managed care payers should be cognizant of the potential ramifications of severe RSV disease in infants. Developing a proactive RSV management strategy can help improve health outcomes and reduce unnecessary hospital resource use.

摘要

严重呼吸道合胞病毒(RSV)疾病表现为细支气管炎或肺炎,是美国1岁以下婴儿住院的主要原因。孕龄35周及以下出生的婴儿尤其容易患严重RSV疾病,这可能导致在出生后的头12个月内频繁入住新生儿重症监护病房(NICU)或长时间住院,并增加医疗保健的使用。这种护理成本高昂——有RSV住院史的孕龄33至36周婴儿的费用几乎是没有RSV住院史的孕龄33至36周婴儿费用的5倍。管理式医疗支付方应认识到婴儿严重RSV疾病的潜在影响。制定积极的RSV管理策略有助于改善健康结果并减少不必要的医院资源使用。

相似文献

1
Impact of RSV: implications for managed care.呼吸道合胞病毒的影响:对管理式医疗的启示
Manag Care. 2009 Jan;18(1 Suppl 2):2-7.
2
Total healthcare costs in the US for preterm infants with respiratory syncytial virus lower respiratory infection in the first year of life requiring medical attention.美国一岁内因呼吸道合胞病毒下呼吸道感染而需要医疗护理的早产婴儿的总医疗费用。
Curr Med Res Opin. 2009 Nov;25(11):2795-804. doi: 10.1185/03007990903290894.
3
Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season.在住院率高且季节延长的地区,呼吸道合胞病毒住院人数下降。
Pediatr Infect Dis J. 2006 Dec;25(12):1116-22. doi: 10.1097/01.inf.0000245104.26996.57.
4
Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada.加拿大孕33至35足周出生的早产儿呼吸道合胞病毒预防风险评分工具。
Curr Med Res Opin. 2009 Jul;25(7):1585-91. doi: 10.1185/03007990902929112.
5
Direct cost analyses of palivizumab treatment in a cohort of at-risk children: evidence from the North Carolina Medicaid Program.对一组高危儿童进行帕利珠单抗治疗的直接成本分析:来自北卡罗来纳医疗补助计划的证据。
Pediatrics. 2004 Dec;114(6):1612-9. doi: 10.1542/peds.2004-0959.
6
FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.FLIP-2研究:与西班牙出生的孕龄32至35周早产儿因呼吸道合胞病毒感染需住院治疗相关的危险因素
Pediatr Infect Dis J. 2008 Sep;27(9):788-93. doi: 10.1097/INF.0b013e3181710990.
7
Healthcare costs within a year of respiratory syncytial virus among Medicaid infants.医疗补助计划婴儿呼吸道合胞病毒感染一年内的医疗费用。
Pediatr Pulmonol. 2010 Aug;45(8):772-81. doi: 10.1002/ppul.21244.
8
RSV disease in the pediatric population: epidemiology, seasonal variability, and long-term outcomes.儿科人群中的呼吸道合胞病毒疾病:流行病学、季节变异性及长期预后
Manag Care. 2008 Nov;17(11 Suppl 12):3-6, discussion 18-9.
9
Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.呼吸道合胞病毒感染对足月儿和早产儿住院治疗的结局及费用影响
J Perinatol. 2016 Nov;36(11):990-996. doi: 10.1038/jp.2016.113. Epub 2016 Aug 4.
10
Comparative costs of hospitalisation among infants at high risk for respiratory syncytial virus lower respiratory tract infection during the first year of life.比较有发生呼吸道合胞病毒下呼吸道感染风险的婴儿在生命的第一年住院费用。
J Med Econ. 2010 Mar;13(1):136-41. doi: 10.3111/13696990903583404.

引用本文的文献

1
Burden of Severe Respiratory Syncytial Virus Disease Among 33-35 Weeks' Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons.多个呼吸道合胞病毒流行季节出生的孕33 - 35周龄婴儿中严重呼吸道合胞病毒疾病的负担
Pediatr Infect Dis J. 2017 Feb;36(2):160-167. doi: 10.1097/INF.0000000000001377.
2
Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease.确定无慢性肺病或先天性心脏病的早产儿中严重呼吸道合胞病毒感染的风险及相关发病率和死亡率。
Infect Dis Ther. 2016 Dec;5(4):417-452. doi: 10.1007/s40121-016-0130-1. Epub 2016 Sep 14.
3
Respiratory syncytial virus market.
呼吸道合胞病毒市场。
Nat Rev Drug Discov. 2010 Jan;9(1):15-6. doi: 10.1038/nrd3075.